compound 20

long-acting RIPK2 degrader (SC admin.)

in vivo degradation of RIPK2 over 60 days

IAP binder linked to RIPK2 binder

Journal of Medicinal Chemistry

GlaxoSmithKline, Stevenage, UK

The GSK RIPK2 PROTAC, “compound 20”, demonstrates in vivo degradation of RIPK2 over 60 days after a single compound dose when administered SC in slow-release PLGA microparticles. This degrader…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks